On a roll in Ireland, Alexion plots 200-job supply chain hub

Alexion ($AXLN), like many of its pharma peers, has moved some operations to Ireland to enjoy the country's low tax rate. Now, it's beefing up those operations: Thursday, the rare-disease drugmaker announced plans for its third Irish project, a new supply-chain facility that should produce around 200 jobs come 2016. More

Suggested Articles

New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.

Could Monday's cancer buyout be a hint about what Sanofi CEO Paul Hudson will unveil at Tuesday's investor confab? Analysts think so.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.